Sep 2026· AI in Medicine· 0 citations· 54 references
TL;DR
This systematic review synthesises peer-reviewed studies published between 2014 and 2025 that exclusively applied DL techniques to breast MRI for cancer classification, prediction, or segmentation and demonstrates that DL models consistently achieve high diagnostic performance and have the potential to enhance radiological workflows by supporting automated lesion detection and clinical decision-making.
Abstract
Breast cancer remains one of the leading causes of cancer-related mortality among women worldwide, underscoring the importance of early and accurate diagnosis to improve patient outcomes. Magnetic resonance imaging (MRI) is a highly sensitive imaging modality for detecting breast malignancies, particularly in patients with dense breast tissue or those at high risk, where conventional imaging techniques may have limited sensitivity. Recent advances in deep learning (DL) have demonstrated considerable potential for improving the automated analysis of breast MRI, including tumour classification, prediction, and segmentation. This systematic review synthesises peer-reviewed studies published between 2014 and 2025 that exclusively applied DL techniques to breast MRI for cancer classification, prediction, or segmentation. The included studies were critically evaluated with respect to model architectures, dataset characteristics, image preprocessing methods, validation strategies, and reported performance metrics. The reviewed literature demonstrates that DL models consistently achieve high diagnostic performance and have the potential to enhance radiological workflows by supporting automated lesion detection and clinical decision-making. However, several challenges continue to limit their translation into routine clinical practice, including limited access to large, diverse, and well-annotated datasets, inadequate external validation, variability in MRI acquisition protocols, and concerns regarding model interpretability and generalisability. Future research should prioritise the development of robust, explainable, and clinically validated DL models trained on multicentre datasets using standardised evaluation frameworks. Addressing these challenges will be essential to improve the reliability, reproducibility, and clinical applicability of AI-assisted breast cancer diagnosis using MRI.
The results indicate that model performance is significantly influenced by data modality and that artificial intelligence may serve as a valuable computational tool to support clinical breast cancer diagnosis workflow.
ABSTRACT Introduction Cervical cancer management relies heavily on magnetic resonance imaging (MRI) for staging and treatment planning; however, manual segmentation is time‐consuming and prone to variability. This systematic review aimed to evaluate the performance and clinical potential of machine learning (ML) and de...
Somayeh Haji Ahmadi, Sina Soltan Mohammadi, Abolfazl Koozari et al.· Journal of Medical Radiation...· 0 citations
DL models applied to breast MRI showed potential for noninvasive TNBC identification with high diagnostic accuracy, however, limited external validation and variability in methodological quality highlight the need for standardized, multicenter studies before clinical implementation can be considered.
S. Mohammadzadeh, I. Kiani, Seyed Mohammad Mehdi Rahmani et al.· European Journal of Radiolog...· 0 citations
Breast cancer imaging is central to screening, diagnosis, staging, treatment monitoring, and post-treatment surveillance, but image interpretation remains limited by variable image quality, interobserver variability, false-positive findings and heterogeneous tumor biology. This narrative review summarizes current appli...
D. Bartusik-Aebisher, Sara Czech, Jakub Szpara et al.· Applied Sciences· 0 citations
Artificial intelligence shows substantial potential to enhance breast cancer imaging, but broader clinical translation requires robust external and prospective validation, improved calibration, assessment of generalizability and bias, and integration into clinical workflows.
I. Khan, Syed Taimoor Hussain Shah, Alexandra Tsipourakis et al.· Frontiers in Imaging· 0 citations
A minimal-feature radiomics model derived exclusively from ADC images showed promising diagnostic performance for differentiating malignant from benign prostate lesions, and may provide a practical, reproducible, and resource-efficient strategy for supporting prostate cancer diagnosis.
Kun Zhang, Jia-Jun Zhang, Yangguang Yuan et al.· Frontiers in Oncology· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.